Thermalin
Waban, US · Founded 2016 · Delaware corporation · 1 known investors
Developer of next-generation insulin solutions
Founders & leadership
RB
Richard BerensonNamed on SEC filing
DC
David C. SweeneyNamed on SEC filing
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$19.5M disclosed across 2 rounds · 2017–2019
▶$17.1MraisedAug 2019 · 6 investors · BiotechnologyRule 506(b)
▶$17.1MraisedAug 2019 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David C. SweeneyDirector
- John BrooksDirector
- Tim XiaoDirector
- Richard BerensonExecutive Officer, Director, Promoter
- Offering amount
- $23M
- Amount sold
- $17.1M
- Sales commissions
- $367.3K
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$2.3MraisedAug 2019 · 5 investors · BiotechnologyRule 506(b)
▶$2.3MraisedAug 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard BerensonExecutive Officer, Director, Promoter
- Tim XiaoDirector
- David C. SweeneyDirector
- John BrooksDirector
- Offering amount
- $10.8M
- Amount sold
- $2.3M
- Sales commissions
- $58K
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Thermalin do?
- Developer of next-generation insulin solutions
- Who are Thermalin's investors?
- Thermalin's investors include Delos Capital.
- How much funding has Thermalin raised?
- Thermalin has disclosed $19.5M raised across 2 rounds.
- Where is Thermalin headquartered?
- Thermalin is headquartered in Waban, US.
